283 related articles for article (PubMed ID: 31919754)
21. A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications.
Earl J; Calabuig-Fariñas S; Sarasquete ME; Muinelo Romay L; Lopez-Tarruella S; Bellosillo Paricio B; Rodríguez M; Valencia Leoz K; Dueñas Porto M; Tarazona N; Hernandez Losa J; Toledo RA
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190291
[TBL] [Abstract][Full Text] [Related]
22. Role of liquid biopsies in colorectal cancer.
Wills B; Gorse E; Lee V
Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
[TBL] [Abstract][Full Text] [Related]
23. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
Eigeliene N; Saarenheimo J; Jekunen A
Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
[TBL] [Abstract][Full Text] [Related]
24. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
25. Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.
Lustberg MB; Stover DG; Chalmers JJ
Cancer J; 2018; 24(2):61-64. PubMed ID: 29601331
[TBL] [Abstract][Full Text] [Related]
26. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
[TBL] [Abstract][Full Text] [Related]
27. Integrating minimal residual disease monitoring into clinical practice for NSCLC: Is the era upon us?
Li Z; Lu S
Cancer Cell; 2023 Oct; 41(10):1699-1701. PubMed ID: 37816330
[TBL] [Abstract][Full Text] [Related]
28. Molecular Profiling of Liquid Biopsy Samples for Precision Medicine.
Campos CDM; Jackson JM; Witek MA; Soper SA
Cancer J; 2018; 24(2):93-103. PubMed ID: 29601336
[TBL] [Abstract][Full Text] [Related]
29. The Emerging Role of Liquid Biopsies in Lymphoproliferative Disorders.
Crombie J; Armand P
Curr Hematol Malig Rep; 2019 Feb; 14(1):11-21. PubMed ID: 30811017
[TBL] [Abstract][Full Text] [Related]
30. [Breakthrough Technologies: Liquid Biopsy -Chairmen's Introductory Remarks.].
Nakatani K; Furuta K
Rinsho Byori; 2016 May; 64(4):392-393. PubMed ID: 29182804
[TBL] [Abstract][Full Text] [Related]
31. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.
Li X; Seebacher NA; Hornicek FJ; Xiao T; Duan Z
Cancer Lett; 2018 Dec; 439():66-77. PubMed ID: 30223067
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Pantel K; Alix-Panabières C
Nat Rev Clin Oncol; 2019 Jul; 16(7):409-424. PubMed ID: 30796368
[TBL] [Abstract][Full Text] [Related]
33. [Genomic Analysis and Immunotherapy by Liquid Biopsy].
Iinuma H
Gan To Kagaku Ryoho; 2019 Sep; 46(9):1361-1366. PubMed ID: 31530771
[TBL] [Abstract][Full Text] [Related]
34. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
Muinelo-Romay L; Casas-Arozamena C; Abal M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
[TBL] [Abstract][Full Text] [Related]
35. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
Fontanilles M; Duran-Peña A; Idbaih A
Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
[TBL] [Abstract][Full Text] [Related]
36. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
[TBL] [Abstract][Full Text] [Related]
37. The Use of Non-Tumor-Related Liquid Biopsy in Respiratory Medicine.
Alcázar-Navarrete B; Romero-Palacios PJ;
Arch Bronconeumol (Engl Ed); 2019 Nov; 55(11):555-556. PubMed ID: 31377108
[No Abstract] [Full Text] [Related]
38. Exosome: An Emerging Source of Biomarkers for Human Diseases.
Xu L; Wu LF; Deng FY
Curr Mol Med; 2019; 19(6):387-394. PubMed ID: 31288712
[TBL] [Abstract][Full Text] [Related]
39. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
Junqueira-Neto S; Batista IA; Costa JL; Melo SA
Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
[TBL] [Abstract][Full Text] [Related]
40. A frontline defense against neurodegenerative diseases:the development of early disease detection methods.
Baldacci F; Lista S; Vergallo A; Palermo G; Giorgi FS; Hampel H
Expert Rev Mol Diagn; 2019 Jul; 19(7):559-563. PubMed ID: 31159600
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
